secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001193125-24-167489
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva settles Israeli tax dispute for ~$750M over 2008-2020, plus up to $500M contingent
--------------------------------------------------------------------------------

- Teva to pay ~$750M to Israeli Tax Authorities over 2024-2029 for tax years 2008-2020.
- Includes ~$500M corporate taxes on previously tax-exempt earnings under Encouragement for Capital Investment Law.
- Additional ~$250M for other disputed tax issues in the same period.
- Contingent payment of 5%-7% of future dividends/repurchases, capped at ~$500M.
- Settlement ends litigation with ITA over historical tax years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312524167489/0001193125-24-167489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312524167489/d839417d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-167489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer